sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements." ;
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
    dce:title "BEL Framework Large Corpus Document" ;
    pav:authoredBy sub:_5 ;
    pav:version "1.4" .
  sub:_4 prov:value "To examine whether HRG signaling results in increased nuclear translocation of beta -catenin, we co-stained control and HRG-activated (30 min) cells with E-cadherin- and beta -catenin-specific antibodies and analyzed by confocal microscopy (Fig. 1D). We found that in addition to an increase within the cytoplasm, there was a significant enhancement of beta -catenin immunostaining inside the nucleus of HRG-treated cells (Fig. 1, lower panel). This was accompanied by cell-shape changes with appearance of some beta -catenin and E-cadherin immunoreactivity at the cellular free edges (Fig. 1D, arrows). In contrast, in control untreated cells, beta -catenin was almost exclusively restricted at the level of intercellular junctions (Fig. 1D, upper panel)." ;
    prov:wasQuotedFrom pubmed:11328805 .
  sub:_5 rdfs:label "Selventa" .
  sub:assertion prov:hadPrimarySource pubmed:11328805 ;
    prov:wasDerivedFrom beldoc: , sub:_4 .
}